Nuray Aktay Ayaz

Treatment with Biologic Drugs in Pediatric Behçet’s Disease: A Comprehensive Analysis of the Published Data

S. Ozen, S. Şener, E. D. Batu, 2023, BioDrugs.

Musculoskeletal Complaints: When Should We Consult a Pediatric Rheumatologist?

H. E. Sönmez, Ş. Karadağ, N. Aktay Ayaz, 2022, The Journal of Pediatric Academy.

Anti-Interleukin 1 Treatment for Patients with Familial Mediterranean Fever Resistant to Colchicine

S. Özen, N. Aktay Ayaz, M. Calguneri, 2011, The Journal of Rheumatology.

Childhood-onset systemic lupus erythematosus: A descriptive and comparative study of clinical, laboratory, and treatment characteristics in two populations.

B. Sözeri, Y. Bilginer, Vafa Guliyeva, 2024, Lupus.

Approach to switching biologics in juvenile idiopathic arthritis: a real-life experience

Rahime Koç, H. E. Sönmez, Ş. Karadağ, 2021, Rheumatology International.

Anakinra treatment in multisystemic inflammatory syndrome in children (MIS-C) associated with COVID-19

H. E. Sönmez, M. Çakan, N. Aktay Ayaz, 2022, Frontiers in Pediatrics.

ADA2 Deficiency: Case Series of Five Patients with Varying Phenotypes

H. E. Sönmez, M. Çakan, Ş. Karadağ, 2019, Journal of Clinical Immunology.